¼¼°èÀÇ B2B Ç×°õÆÎÀÌÁ¦ ½ÃÀå(2025³â)
Global B2B Mold Inhibitors Market Research Report 2025
»óǰÄÚµå : 1660874
¸®¼­Ä¡»ç : QYResearch
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,900 £Ü 4,096,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,350 £Ü 6,144,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ³»¿ëÀÇ ÅØ½ºÆ® µîÀ» Copy & Paste ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,192,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü ¼¼°è B2B Ç×°õÆÎÀÌÁ¦ ½ÃÀå ±Ô¸ð(¸ÅÃâ ±âÁØ)´Â 2024³â 1¾ï 5,693¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 2¾ï 3,983¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 5.20%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¸ÅÃâ¾×Àº 2024³â 7,753Åæ¿¡¼­ 2031³â±îÁö 11,820Åæ¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â ¿¬Æò±Õ 5.84%·Î ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

ºÏ¹Ì ½ÃÀå ±Ô¸ð´Â 2024³â 4,428¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 5,865¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â ¿¹Ãø ±â°£ µ¿¾È 4.04%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯·´ÀÇ ½ÃÀå ±Ô¸ð´Â 2024³â 4,003¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 5,697¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 3.57%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀå ±Ô¸ð´Â 2024³â 6,038¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö 1¾ï 656¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2031³â ¿¹Ãø ±â°£ µ¿¾È 7.11%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è B2B Ç×°õÆÎÀÌÁ¦ ÁÖ¿ä Á¦Á¶¾÷ü´Â Sanitized, Guangdong Dimei Biological Technology, Sinanen Zeomic, 3D Bio-chem, Thermaset, iHeir, Daiko Technical, Colloids, I'm Biotechnology, Guangzhou Good Nice Anti-Mold µîÀ̸ç, 2024³â ¼¼°è »óÀ§ 5°³ ¾÷ü°¡ ¸ÅÃâÀÇ ¾à 48.32%¸¦ Â÷ÁöÇß½À´Ï´Ù.

¼¼°èÀÇ B2B Ç×°õÆÎÀÌÁ¦ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, °¢ Áö¿ªº° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, °æÀï »óȲ, ÁÖ¿ä °æÀï»ç, ±â¼ú µ¿Çâ, ½ÅÁ¦Ç° °³¹ß µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå B2B Ç×°õÆÎÀÌÁ¦ ½ÃÀå °³¿ä

Á¦2Àå °¢ Á¦Á¶¾÷ü ½ÃÀå °æÀï

Á¦3Àå B2B Ç×°õÆÎÀÌÁ¦ »ý»ê : Áö¿ªº°

Á¦4Àå B2B Ç×°õÆÎÀÌÁ¦ ¼Òºñ : Áö¿ªº°

Á¦5Àå ºÎ¹® : À¯Çüº°

Á¦6Àå ºÎ¹® : ¿ëµµº°

Á¦7Àå ÁÖ¿ä ±â¾÷ °³¿ä

Á¦8Àå »ê¾÷ üÀΰú ÆÇ¸Å ä³Î ºÐ¼®

Á¦9Àå B2B Ç×°õÆÎÀÌÁ¦ ½ÃÀå ¿ªÇÐ

Á¦10Àå Á¶»ç °á°ú¿Í °á·Ð

Á¦11Àå Á¶»ç ¹æ¹ý°ú Á¤º¸ Ãâó

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global B2B Mold Inhibitors market size in terms of revenue is projected to reach 239.83 million USD by 2031 from 156.93 million USD in 2024, with a CAGR 5.20% during 2025-2031. Global B2B Mold Inhibitors market size in terms of sales is projected to reach 11,820 Tons by 2031 from 7,753 Tons in 2024, with a CAGR 5.84% during 2025-2031.

North America market for B2B Mold Inhibitors is estimated to increase from 44.28 million USD in 2024 to reach 58.65 million USD by 2031, at a CAGR of 4.04% during the forecast period of 2025 through 2031.

Europe market for B2B Mold Inhibitors is estimated to increase from 40.03 million USD in 2024 to reach 56.97 million USD by 2031, at a CAGR of 3.57% during the forecast period of 2025 through 2031.

Asia-Pacific market for B2B Mold Inhibitors is estimated to increase from 60.38 million USD in 2024 to reach 106.56 million USD by 2031, at a CAGR of 7.11% during the forecast period of 2025 through 2031.

The major global manufacturers of B2B Mold Inhibitors include Sanitized, Guangdong Dimei Biological Technology, Sinanen Zeomic, 3D Bio-chem, Thermaset, iHeir, Daiko Technical, Colloids, I'm Biotechnology, Guangzhou Good Nice Anti-Mold, etc. In 2024, the world's top five vendors accounted for approximately 48.32% of the revenue.

This report aims to provide a comprehensive presentation of the global market for B2B Mold Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B2B Mold Inhibitors.

The B2B Mold Inhibitors market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global B2B Mold Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the B2B Mold Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Segment by Type

Segment by Application

Production by Region

Consumption by Region

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of B2B Mold Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of B2B Mold Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of B2B Mold Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 B2B Mold Inhibitors Market Overview

2 Market Competition by Manufacturers

3 B2B Mold Inhibitors Production by Region

4 B2B Mold Inhibitors Consumption by Region

5 Segment by Type

6 Segment by Application

7 Key Companies Profiled

8 Industry Chain and Sales Channels Analysis

9 B2B Mold Inhibitors Market Dynamics

10 Research Findings and Conclusion

11 Methodology and Data Source

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â